381 related articles for article (PubMed ID: 27158534)
1. Barrett's esophagus in 2016: From pathophysiology to treatment.
Martinucci I; de Bortoli N; Russo S; Bertani L; Furnari M; Mokrowiecka A; Malecka-Panas E; Savarino V; Savarino E; Marchi S
World J Gastrointest Pharmacol Ther; 2016 May; 7(2):190-206. PubMed ID: 27158534
[TBL] [Abstract][Full Text] [Related]
2. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
3. Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device.
Heberle CR; Omidvari AH; Ali A; Kroep S; Kong CY; Inadomi JM; Rubenstein JH; Tramontano AC; Dowling EC; Hazelton WD; Luebeck EG; Lansdorp-Vogelaar I; Hur C
Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1397-1404.e7. PubMed ID: 28238953
[TBL] [Abstract][Full Text] [Related]
4. Screening for Barrett's Esophagus: Balancing Clinical Value and Cost-effectiveness.
Patel A; Gyawali CP
J Neurogastroenterol Motil; 2019 Apr; 25(2):181-188. PubMed ID: 30827080
[TBL] [Abstract][Full Text] [Related]
5. Barrett's esophagus.
Shalauta MD; Saad R
Am Fam Physician; 2004 May; 69(9):2113-8. PubMed ID: 15152957
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic surveillance or ablation for Barrett's esophagus?
Inadomi JM; Saxena N
Transl Gastroenterol Hepatol; 2018; 3():102. PubMed ID: 30701209
[TBL] [Abstract][Full Text] [Related]
7. The value of medical imaging in uncomplicated and complicated Barrett's esophagus.
De Backer AI; De Schepper AM; Pelckmans P
Acta Gastroenterol Belg; 2000; 63(1):22-8. PubMed ID: 10907315
[TBL] [Abstract][Full Text] [Related]
8. Precision care for Barrett's esophagus.
Triadafilopoulos G; Friedland S
Transl Gastroenterol Hepatol; 2018; 3():67. PubMed ID: 30363757
[TBL] [Abstract][Full Text] [Related]
9. Current state of prognostication, therapy and prospective innovations for Barrett's-related esophageal adenocarcinoma: a literature review.
Mittal SK; Abdo J; Adrien MP; Bayu BA; Kline JR; Sullivan MM; Agrawal DK
J Gastrointest Oncol; 2021 Aug; 12(4):1197-1214. PubMed ID: 34532080
[TBL] [Abstract][Full Text] [Related]
10. Molecular targets for treatment of Barrett's esophagus.
Feagins LA; Souza RF
Dis Esophagus; 2005; 18(2):75-86. PubMed ID: 16053481
[TBL] [Abstract][Full Text] [Related]
11. Optimizing the diagnosis and therapy of Barrett's esophagus.
Muñoz-Largacha JA; Fernando HC; Litle VR
J Thorac Dis; 2017 Mar; 9(Suppl 2):S146-S153. PubMed ID: 28446978
[TBL] [Abstract][Full Text] [Related]
12. Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma.
Singh A; Chak A
Gastroenterol Rep (Oxf); 2015 Nov; 3(4):303-15. PubMed ID: 26486568
[TBL] [Abstract][Full Text] [Related]
13. Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.
Hammad TA; Thrift AP; El-Serag HB; Husain NS
Dig Dis Sci; 2019 Feb; 64(2):367-372. PubMed ID: 30370493
[TBL] [Abstract][Full Text] [Related]
14. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
15. The controversy regarding ablation for Barrett's esophagus without dysplasia.
Gaddam S; Muthusamy R; Sharma P
Curr Opin Gastroenterol; 2011 Jul; 27(4):368-73. PubMed ID: 21577102
[TBL] [Abstract][Full Text] [Related]
16. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
17. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
[TBL] [Abstract][Full Text] [Related]
18. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
19. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
Schlottmann F; Molena D; Patti MG
Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
[TBL] [Abstract][Full Text] [Related]
20. Barrett's esophagus: best practices for treatment and post-treatment surveillance.
Mansour NM; El-Serag HB; Anandasabapathy S
Ann Cardiothorac Surg; 2017 Mar; 6(2):75-87. PubMed ID: 28446996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
